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Background: Ribosomes and functional complexes of them have been analyzed at the atomic level. Far less is
known about the dynamic assembly and degradation events that define the half-life of ribosomes and guarantee
their quality control.
Results: We developed a system that allows visualization of intact ribosomal subunits and assembly intermediates
(i.e. assembly landscapes) by convenient fluorescence-based analysis. To this end, we labeled the early assembly
ribosomal proteins L1 and S15 with the fluorescent proteins mAzami green and mCherry, respectively, using
chromosomal gene insertion. The reporter strain harbors fluorescently labeled ribosomal subunits that operate
wild type-like, as shown by biochemical and growth assays. Using genetic and chemical perturbations by depleting
genes encoding the ribosomal proteins L3 and S17, respectively, or using ribosome-targeting antibiotics, we
provoked ribosomal subunit assembly defects. These defects were readily identified by fluorometric analysis after
sucrose density centrifugation in unprecedented resolution.
Conclusion: This strategy is useful to monitor and characterize subunit specific assembly defects caused by
ribosome-targeting drugs that are currently used and to characterize new molecules that affect ribosome assembly
and thereby constitute new classes of antibacterial agents.
Keywords: Ribosome assembly, Ribosome biogenesis, Fluorescent proteins, Antimicrobials, Knock out, λ-red
recombineering, High throughput screeningBackground
The bacterial 70S ribosome is formed by a small 30S- and
a large 50S subunit. While the small subunit consists of
one 16S ribosomal RNA (rRNA) and 21 ribosomal proteins
(r-proteins), the large subunit contains two rRNAs (23S
and 5S rRNA) and 33 r-proteins [1]. Reconstitution of in-
tact ribosomal subunits in the test tube is possible using
components derived from purified ribosomes, but requires
non-physiological conditions, such as high Mg2+ concen-
tration and incubation temperatures of up to 50°C [2,3]. In
vivo, this process critically depends on biogenesis factors,
which are proteins that process, modify and chaperone
rRNA or r-proteins [4,5]. Ribosome assembly is character-
ized by a highly coordinated sequence of events consisting
of rRNA synthesis and r-protein uptake. Since assembly
takes place co-transcriptionally (i.e. during rRNA synthesis)
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unless otherwise stated.and late assembly r-proteins [5,6]. Each r-protein gene is
present in a single copy per genome, whereas rRNAs are
encoded by multiple rrn operons (seven ones in E. coli).
One 16S, 23S and 5S rRNA (and several tRNAs) are con-
tained in one primary transcript that is processed by site
specific RNases [4]. Due to this genetic organization ribo-
somal subunits are consequently produced in equal stoi-
chiometric amounts. Furthermore, synthesis of rRNA and
r-proteins are synchronized [7] with the consequence that
free cytosolic pools of r-proteins are close to zero under
optimal conditions [8-10]. In addition, ribosome assembly
is a fast process taking place within a couple of minutes at
37°C [11]. It follows that r-proteins upon synthesis are rap-
idly taken up by nascent ribosomal subunits. If selected r-
proteins were fluorescence labeled, it further follows that
the fluorescences signal would represent subunit precur-
sors and whole subunits rather than free cytosolic pools of
r-proteins.
Treatment of cells with chemical agents or occurrence
of mutations (e.g. affecting genes encoding r-proteins or. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[12]. One possible fate of defective assembly intermediates
is a selective clearance by RNase based control mecha-
nisms [13,14]. Alternatively, assembly intermediates can
accumulate and possibly mature into intact subunits, as
soon as the source of defect is eliminated [5,12,15-18].
Analyses of protein and RNA content of ribosomal as-
sembly intermediates are possible using quantitative mass
spectrometry approaches and cryo-electron microscopy
[19-25]. Analyses of sucrose gradient fractions by agarose
and two-dimensional gel electrophoresis with subsequent
quantitation of rRNA and r-proteins are established
methods but time-consuming and insensitive to small dif-
ferences in quantity and quality.
Therefore, we set out to establish a convenient fluorescence-
based method to assess amounts and assembly-states of
ribosomal particles.
In our previous approach [26] late assembly r-proteins
were labeled with fluorescent proteins (FPs) to monitor
and compare the intact portions of both ribosomal sub-
units. In this study intact ribosomal subunits and assem-
bly intermediates of all maturation states are detectable
by labeling early assembly r-proteins. A reporter strain
harboring the fusion proteins L1-mAzami green (a
coral-derived monomeric green fluorescent protein [27],
hereafter mAzami) and S15-mCherry was constructed
and exhibited normal growth, indicating an intact trans-
lation apparatus. We used synthetic gene knock out of
rplC (encoding L3) and rpsQ (encoding S17), respect-
ively, or ribosome directed antibiotics to induce subunit
assembly defects. A254 and fluorescence analysis of su-
crose gradient centrifugates allowed in vitro analysis of
ribosomal subunits and all of their assembly intermedi-
ates in unprecedented resolution.
Results
Rationale
In order to generate a reporter strain suitable for monitor-
ing ribosome assembly landscapes, we selected ribosomal
protein candidates from each subunit according to the fol-
lowing criteria [28,29]: The candidates should be i) distant
from functional sites, ii) accessible to C-terminal tagging
with fluorescent proteins, iii) early assembly proteins [10]
and iv) subject of feedback regulation. The ribosomal pro-
teins S15 and L1 fulfill all these criteria: Their surface ex-
posed C-termini (Additional file 1A) allow convenient
tagging (with mCherry and mAzami). Although these pro-
teins are not essential [30] deletion strains have exagger-
ated generation times at 37°C. In addition, absence of S15
results in severe cold sensitivity [31] and ribosomes lack-
ing L1 show 50% reduced translation activity in vitro [32].
Therefore, growth would be severely hampered if the fu-
sion proteins do not fully complement the wild type pro-
tein’s function. According to in vivo ribosome assemblymaps (Additional file 2), both are early assembly proteins
and consequently present in ribosomal particles of each
state of maturation. Finally, feedback regulation by au-
togenous control [33,34] ensures that they are not pro-
duced in excess.
Phenotypic and biochemical characterization of the
engineered strains
To generate E. coli strains harboring modified genes cod-
ing for S15-mCherry (MCr*) and L1-mAzami (MCg*) fu-
sion proteins (Additional file 1B), we used the technique
of lambda red recombineering [35,36]. The final reporter
strain MCrg* producing both S15-mCherry and L1-
mAzami fusion proteins was constructed, using P1 phage
transduction.
To exclude that tagging of r-proteins with FPs inter-
feres with regular cell functions and growth, we analyzed
reporter strains in more detail. Spot tests revealed that
growth of the genetically engineered strains did not
differ from that of the wild type strain at various temper-
atures (Figure 1A). To analyze possible growth differences
more precisely, all strains were grown to stationary phase
at different temperatures and their growth rates were cal-
culated (Figures 1B). It turned out that the growth rate of
MCrg* at 37°C was 5-10% less than the wild type strain.
Next, the protein content of MCr*, MCg* and MCrg*-
derived ribosomes was analyzed by SDS-PAGE and
immunoblotting (Figure 1C, D). While MCr* and MCg*
ribosomes contained one fusion protein (migrating at 37
and 57 kDa, respectively), two fusion proteins were
observed in MCrg* ribosomes.
Collectively, the data indicate that growth behavior
and functional competence of the ribosomes of MCrg*
are similar to those of the parental strain.
Generation of ribosome subunit specific assembly defects
and in vitro analysis
To induce assembly defects in the small or the large ribo-
somal subunit, conditional gene knock outs of rpsQ (en-
coding S17) and rplC (encoding L3), respectively, were
generated in the reporter strain background (Additional
file 1A). It has been shown previously that defects in each
of these genes caused ribosome assembly defects that were
supposed to be subunit specific [26,37,38].
The resulting strains (MCrg*ΔsQ and MCrg*ΔlC) car-
ried plasmids containing wild type copies of the genes
deleted from the chromosome under control of an IPTG
inducible promoter. The withdrawal of IPTG in liquid
cultures should result in impaired growth and in subunit
specific assembly defects [39] as soon as the number of
intact ribosomes becomes limiting.
To this end, we grew MCrg*, MCrg*ΔsQ and -ΔlC cells in
the absence of IPTG to mid-logarithmic phase and examined
the ribosomes by sucrose gradient ultracentrifugation and
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Figure 1 Physiological and biochemical characterization. (A) Growth comparison on solid medium: Cells of the indicated strains were
spotted onto LB agar in a serial dilution and incubated at the given temperatures. (B) Cells as indicated were grown at 20, 37 and 42°C to
stationary phase. Growth rates were calculated and normalized values are given for each strain at each incubation temperature. Data were
obtained from three independent experiments. Ribosomes from the indicated strains were isolated by sucrose cushion centrifugation and
subjected to SDS-PAGE (C) and western blot analysis (D). For immunodetection, S15 and L1 specific antisera were used. Note that S15 wild
type protein was not resolved by SDS-PAGE and immunoblotting. Asterisks denote unspecific protein bands.
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somes showed the expected pattern consisting of 30S-,
50S-, 70S-, and polysome peaks (Figure 2A), whereas de-
pletion of rpsQ (Figure 2B) led to dramatically reduced
amounts of 70S ribosomes and polysomes, increased
amounts of 50S subunits and a broad peak of particles in
the region of the 30S subunits. Likewise, depletion of rplC
reduced the amount of 70S ribosomes and led to a defined
peak of 30S subunits and a large and broad peak of
particles migrating between mature 50S and 30S subunits
(Figure 2C). This was expected because both absence
of rpsQ and rplC should result in defective small and
large ribosomal subunits, respectively. Consequently, thereduced number of functional subunits limited the amount
of monosomes and polysomes.
Fluorometric analysis of the sucrose fractions provided
fluorescence profiles of MCrg*, MCrg*ΔsQ and -ΔlC de-
rived ribosomes (Figures 2D-F). Comparing A254 and
fluorescence profiles of MCrg* ribosomes (Figure 2G)
revealed reasonable coincidence of the individual peaks.
For completeness the entire profile, also including early
low molecular weight fractions, is depicted as insert
(Figure 2G, insert).
When analyzing A254 and fluorescence profiles of
MCrg*ΔsQ ribosomes by overlay (Figure 2H) several









Figure 2 Polysome analysis and fluorescence detection of sucrose fractions. Cells were grown in M9 medium at 37°C to OD600 = 0.4 and
harvested. Lysates were subjected to sucrose gradient centrifugation. Centrifugates were analyzed by A254 detection and fractionated. Polysome
profiles derived from: (A) MCrg*, (B) MCrg*ΔsQ, (C) MCrg*ΔlC. Sucrose gradient fractions of samples A-C were analyzed for mAzami- and
mCherry specific fluorescence and normalized results are given in bar charts for: (D) MCrg* (E) MCrg*ΔsQ (F) MCrg*ΔlC. Superposition of A254
profiles and corresponding fluorescence bar charts: (G) MCrg*, (H) MCrg*ΔsQ, (J) MCrg*ΔlC. The inserts show fluorescence analysis of all available
fractions from each sucrose gradient run. Red bars: normalized mCherry fluorescence; Green bars: normalized mAzami fluorescence. Fluorescence
was normalized to the first polysome peak (“disome”) where subunits are supposed to be present in 1:1 ratio. Experiments were done in
duplicates, representative profiles are shown.
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creased in intensity relative to largest peak of green
fluorescence -representing the large subunit- (in com-
parison with Figure 2G). Moreover, the red fluorescence
peak was in addition left shifted due to absence of rpsQ.
The largest peak of green fluorescence was slightly left
shifted and showed a shoulder at the lower left side over-
lapping with the red peak, indicating defective large ribo-
somal subunits. This indicates that a selective assembly
defect of the small subunit is also associated with an accu-
mulation of 50S assembly intermediates. Finally, as shown
in the insert there was no increased fluorescence in the
low molecular weight fractions, indicating proper autogen-
ous control of S15-mCherry and L1-mAzami.
Combined analysis of A254 and fluorescence profiles of
MCrg*ΔlC ribosomes (Figure 2J) revealed a decrease in
the green fluorescence peak relative to the red fluores-
cence peak, in comparison with Figure 2H. In addition,the green fluorescence peak was clearly left shifted, due
to assembly defects in the absence of rplC. In the A254
profile the peak of the large subunit appeared higher
than the peak of the small subunit. This is presumably
the case because peaks of both subunits are overlapping
each other (Figure 2F), thereby producing a dominant
broad peak in the region of the large subunit. Investiga-
tion of the low molecular weight fractions in the insert
showed strict feedback regulation of S15-mCherry and
L1-mAzami.
In summary, assembly defects of the small and large
ribosomal subunit could be provoked and were readily
detectable by fluorescence analysis of sucrose gradient
centrifugates.
In vivo analysis of subunit specific assembly defects
Next, we asked whether subunit assembly defects could be
detected by fluorescence readout in vivo using MCrg*?
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and S15 results in fluorescent subunits of all stages of mat-
uration. Since both subunits are systemically produced in
equal amounts, any shift in the fluorescence ratios is ex-
pected to be a consequence of subunit specific turnover
(facilitated by ribonucleases and proteases). Increased
turnover of the large subunit should reduce the amount of
green fluorescence and consequently lower the normalized
fluorescence emission ratio of mAzami/mCherry, while in-
creased turnover of the small subunit in turn should in-
crease the ratio.
MCrg*, MCrg*ΔsQ and MCrg*ΔlC cells were trans-
ferred to 384-well plates and incubated at 37°C for
10 hours in M9 medium. Fully automated sample hand-
ling was possible, using a robotic platform equipped with
incubator, microplate reader and robotic arm. Both
A650 values and fluorescence intensities were measured
(Figure 3) in one-hour intervals. From the latter, normal-
ized fluorescence ratios were calculated. While MCrg*
grew unperturbed, MCrg*ΔsQ and MCrg*ΔlC cells
showed impaired growth and reached lower cell dens-
ities after 10 hours (Figure 3A). The background cor-
rected and normalized fluorescence ratios of MCrg*ΔlC
reached a minimum of 0.8 after 6 hours, revealing a defect
of the 50S assembly, whereas the ratios of MCrg*ΔsQ in-
creased instead reaching a maximum of 1.3 after 9 hours
indicating a defect in the 30S assembly (Figure 3B).
We conclude that depletion of rplC and rpsQ, respect-
ively, causes severe assembly defects of ribosomal sub-
units. Moreover, the changes in fluorescence ratios
suggest that there is turnover of defective subunits.
Probing MCrg* with ribosome-targeting antibiotics
It has been shown that translation inhibitors such as chlor-
amphenicol [16,17,40,41], erythromycin [16,17,42,43] and














Figure 3 Growth in 384-well pates and fully automated fluorescence
MCrg*ΔlC cultures were transferred into 384- well plates in quadruplicates.
were made in one-hour intervals. (A) A650 values were determined and (B)
were calculated for MCrg*, MCrg*ΔsQ and MCrg*ΔlC. Fluorescence ratios o
and fluorescence ratios are mean values from four independent experimendefects of both ribosomal subunits. The mechanistic inter-
pretation of the antibiotic mediated effects is controversial
[15-18]. We tested all of the before mentioned antibiotics
and included a fourth one (kanamycin) that, to our know-
ledge, was not investigated so far for its potential to cause
ribosome assembly defects. Using MCrg*, we set out to
clarify, whether treatment of cells with ribosome targeting
antibiotics results in assembly defects of one or both of the
ribosomal subunits. The fact that early assembly proteins
are fluorescently labeled should allow detailed analysis of
the assembly landscapes upon antibiotic treatment. In
addition, cell based assays were used to elicit whether there
are indications for subunit specific turnover.
MCrg* cells were grown in M9 medium for seven hours
in the absence or presence of chloramphenicol (7 μg/ml),
erythromycin (100 μg/ml), kanamycin (7 μg/ml) or neo-
mycin (7 μg/ml). While each antibiotic led to impaired cell
growth (Figure 4A), chloramphenicol caused strongest
growth defects. Erythromycin, kanamycin and neomycin
treatment did not show a significant change in fluores-
cence ratios (Figure 4B). Treatment with chloramphenicol,
by contrast, led to an increased fluorescence ratio, with a
maximum of about 1.20 after 7 hours. This suggests that
treatment of cells with chloramphenicol might decrease
the relative amounts of the small subunit.
This hypothesis was tested by analyzing ribosome pro-
files obtained from MCrg* cells that grew in the pres-
ence of the antibiotics or without (Figure 4C-G).
Figure 4C shows the A254 profile of ribosomes derived
from non-treated cells. The 70S peak and the polysomes
(not shown) were reduced in intensity since no chloram-
phenicol was added prior to harvesting. In our previous
study, it turned out that addition of chloramphenicol
(immediately before harvest) to antibiotic-treated cells
caused extremely broadened 70S peaks. Ribosomes de-





















analysis of reporter strains. Aliquots of MCrg*, MCrg*ΔsQ and
Cells were grown in M9 medium at 37°C for 10 hours. Measurements
mAzami and mCherry fluorescence emission were detected and ratios
f MCrg* were normalized to 1. Data points given in the growth curves
ts; error bars show standard deviation.
Figure 4 (See legend on next page.)
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Figure 4 Testing MCrg* with inhibitors of translation. Cell-based assay: MCrg* cells were cultured in Erlenmeyer flasks at 25°C in M9
medium for 7 hours in the absence and presence of antibiotics, as indicated. Samples were taken every hour. (A) OD600 values were determined
and (B) mAzami and mCherry fluorescence emission were detected and ratios were calculated. Fluorescence ratios of MCrg* were normalized to
1. Exemplary growth curves are given and fluorescence ratios are means from three independent experiments; error bars show standard
deviation. Analyses of isolated ribosomal particles: Sucrose density gradient (10-25%) centrifugation profiles from (C) control cells with no
antibiotic (none), (D) chloramphenicol (Cam), (E) erythromycin (Ery), (F) kanamycin (Kan) and (G) neomycin (Neo) treated cells. Sucrose gradient
fractions from (C) to (G) were analyzed for fluorescence by a microplate reader. A254 profiles and fluorescence bar charts were superimposed for
(H) control cells with no antibiotic (none), (J) chloramphenicol (Cam), (K) erythromycin (Ery), (L) kanamycin (Kan) and (M) neomycin (Neo) treated
cells. Cells in presence and absence of antibiotics were cultured in LB medium at 25°C for 3 hours before subsequent polysome analysis. Left
shifted peaks of the large subunit are indicated by horizontal arrows, abnormal portions of the small subunit by vertical arrows. Red bars:
normalized mCherry fluorescence; Green bars: normalized mAzami fluorescence. Fluorescence was normalized to the first polysome peak
(“disome”) where subunits are present in 1:1 ratio. Experiments were done in duplicates, representative profiles are shown.
Nikolay et al. BMC Molecular Biology  (2015) 16:3 Page 7 of 12treated cells showed reduced and left shifted 50S peaks.
Shifted peaks of the large subunit are indicated with
horizontal arrows, additional peaks and shoulders left-
lateral of the 30S peak are marked with vertical arrows.
Chloramphenicol treatment caused an additional peak
(left-lateral of 30S), while after erythromycin treatment
the 30S peak had a shoulder on the left. Treatment with
kanamycin had no apparent influence on the 50S peak
but provoked an additional peak left-lateral of the 30S
peak (F). Neomycin treatment caused a slight reduction
and left shift of the 50S peak and an additional peak on
the left of the 30S peak (G).
Overlay diagrams (combining A254 and fluorescence
read outs) (Figure 4H-M) show that ribosome profiles
from non-treated cells are congruent (Figure 4H). Profiles
from chloramphenicol and in particular erythromycin
treated cells revealed an extra portion of green fluores-
cence within the region of the 30S peak (Figure 4J-K).
Ribosome profiles derived from kanamycin and neomycin
treated cells possessed additional green fluorescent peaks
of very weak intensity but at similar positions within the
profile (Figure 4L-M). The particles within the green peaks
migrating slower than that of the 50S subunits presumably
represent defective assembly intermediates of the large
subunit that are caused by all the antibiotics used in this
study, but to different extent. For a more detailed analysis
the green fluorescence profiles were aligned and the one
derived from non-treated cells was compared with all the
others obtained from antibiotic treated cells (Additional
file 3), illustrating the presence of assembly intermediates
of the large subunit. Comparison of the red fluorescent
peaks (Figure 4H-M) indicates that treatment with all anti-
biotics produced a more or less pronounced shoulder on
the left side. To analyze potential defects of the small sub-
unit in more detail, the red fluorescence profiles derived
from antibiotic treated cells were compared with the one
obtained from non-treated cells (Additional file 4). It
turned out that treatment with all four antibiotics caused
distinct left-sided shoulders of the red fluorescence peak,
indicating small subunit assembly defects. This is either
due to accumulation of the 21S precursor of the 30Ssubunit, or assembly dead-ends of this subunit. A more
thorough analysis, which includes quantitation of the 16S
and 23S rRNA within the sucrose fractions is given in the
supplementary material (Additional file 5), confirms all
hypothesized assembly intermediates. Taken together, the
administration of a representative collection of ribosome-
targeting antibiotics caused assembly defects of both sub-
units in each case, but to different extents.
In summary, our analyses demonstrated that ribosome
assembly defects are detectable by fluorometric analysis
of fractions collected after sucrose gradient ultracentrifu-
gation of ribosomal preparations. Assembly defects
caused by gene depletions (of rplC and rpsQ) or by treat-
ment of reporter cells with four different ribosome-
targeting antibiotics revealed the presence of defective
assembly intermediates of both ribosomal subunits.
Discussion
Here, we report construction and characterization of
the strain MCrg* harboring large and small ribosomal sub-
units labeled with mAzami and mCherry proteins, respect-
ively. This strain has growth properties similar to the
parental strain. We have provided evidence that the re-
porter strain reveals assembly defects of ribosomal subunits
by fluorescence-based readouts of sucrose density centrifu-
gates and should report differences in subunit specific turn-
over when subjected to fluorescence-based in vivo analysis.
In our previous study, we labeled the late assembly
r-proteins L19 and S2 with FPs to identify and compare
the portion of intact ribosomal subunits. A detailed
characterization of physiological and biochemical prop-
erties of the reporter strain demonstrated that there
were no substantial limitations of the translation appar-
atus resulting from labeling of two ribosomal proteins
with two different FPs. When ribosome assembly had
been perturbed genetically or chemically fluorescence-
based read out allowed identification of these assembly
defects [26].
In the current study, we labeled the early assembly
r-proteins L1 and S15 with FPs. Again, we made sure
that tagging of the r-proteins with FPs did not compromise
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by growth assays and SDS-PAGE analysis of purified ribo-
somes (Figure 1). In addition, we provided evidence that
MCrg* allows for in vitro analysis of isolated ribosomes to
monitor fully matured ribosomal subunits and their as-
sembly intermediates (Figure 2). Moreover, MCrg* is a
strong tool for cell-based assays. It allows fluorometric
in vivo determination of the ratio between the two riboso-
mal subunits, including all assembly states. In untreated
reporter cells this ratio is expected to be one, due to equal
production of ribosomal subunits. A change in the fluores-
cence ratio is therefore interpreted as consequence of un-
equal turnover of ribosomal subunits.
Generation of subunit specific assembly defects by gene
depletion
Subunit specific ribosome assembly defects were in-
duced by depletion of r-protein genes encoding the early
assembly proteins S17 and L3, respectively (Figure 2).
Depletion of rpsQ (encoding S17) caused an assembly
defect of the small subunit (Figure 3E) and increased the
fluorescence ratio by 30% (Figure 3B), indicating in-
creased turnover of the small subunit. Depletion of rplC
(encoding L3) caused an assembly defect of the large
subunit (Figure 2F) and decreased the fluorescence ratio
by 20% (Figure 3B), indicating increased turnover of the
large subunit. It seems that assembly defects on one sub-
unit disturb assembly of the other subunit. It is possible
that assembly defects reduce the pool of active 70S ribo-
somes, thereby reducing levels of translation, which in
turn induces in assembly defects of both subunits (also
see below).
Treatment of MCrg* with ribosome targeting antibiotics
Chloramphenicol and erythromycin target the large ribo-
somal subunit, while kanamycin and neomycin interact
predominantly with the small ribosomal subunit. Chlor-
amphenicol binds to the peptidyl transferase center
(PTC) and inhibits fixation of the CCA-aminoacyl end
of an aminoacyl tRNA at the A-site region of the PTC
[46], while the macrolide erythromycin binds in the
upper region of the ribosomal exit tunnel and hinders
protein synthesis by blocking a full occupation of the
exit tunnel [47]. Kanamycin and neomycin belong to the
aminoglycoside and 2-deoxystreptamine aminoglycoside
families of antibiotics, respectively. They both target the
30S subunit and interact with the internal loop 44 of the
decoding center [48]. For neomycin an additional bind-
ing site within helix 69 of the 23S rRNA was reported
[49,50]. Both antibiotics cause translational misreading
by stabilizing and binding of near cognate tRNAs to the
mRNA [48].
Antibiotics used in this study induce assembly defects
in both ribosomal subunits (Figure 4). This raises thequestion, whether a perturbation of the translation appar-
atus always results in mutual assembly defects? According
to previous studies, inhibition of translation by ribosome
targeting antibiotics reduces protein biosynthesis and pro-
vokes overproduction of rRNA [16,51,52]. Consequently,
there is a stoichiometric imbalance between rRNA and
r-proteins, which promotes accumulation of defective pre-
cursor particles of both ribosomal subunits [5,16]. Siibak
et al. provided evidence that the presence of sublethal con-
centrations of chloramphenicol or erythromycin resulted
in reduced and unbalanced protein biosynthesis [16,17]. In
particular ribosomal proteins were produced in amounts
that correlated with their presence in assembly intermedi-
ates [17]. In that sense assembly defects reflect an indirect
consequence of impaired translation.
In our study defective subunits were monitored by
fluorescence-based in vitro analyses in great detail. Not-
ably, the defects observed in subunit assembly upon
treatment with antibiotics were most reveling (Figure 4,
Additional files 3 and 4). Ribosome profiles clearly dif-
fered both in A254 and in fluorescence analysis. Detailed
analyses of 30S subunit formation in vitro [53] and evi-
dence from in vivo experiments [18] suggest that there
are parallel routes for ribosomal subunit formation.
Therefore, assembly intermediates described here (and
in literature) may reflect a heterogeneous collection of
similar sizes and shapes [5]. This could indicate that the
used antibiotics have intrinsic properties that cause spe-
cific assembly defects with particles slightly differing in
size and composition. Champney and coworkers have
provided evidence, using different bacterial species and
dozens of different antibiotics, that certain ribosome tar-
geting drugs bind to ribosomal precursor particles and
thereby presumably hinder further maturation to intact
subunits [15,54].
Even though mechanistic concepts and causative ex-
planations for ribosome assembly defects caused by
current translation inhibitors differ, attempts to identify
primary inhibitors of ribosome assembly are important
and worthwhile for several reasons:
1. The availability of small molecules that selectively
inhibit the assembly process of one subunit at a
defined stage would clearly be highly appreciated by
researchers in the ribosome field to obtain a more
detailed understanding of subunit specific assembly
in vivo.
2. Such compounds could be the basis for the
development of drugs with a defined target leading
to subunit specific assembly breakdown. Molecules
can be envisioned that exclusively target either
assembly of the large or the small ribosomal subunit.
3. If the latter was possible, these compounds could be
combined in one preparation to achieve defined and
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subunits simultaneously.
Conclusions
The described here fluorescence-based assays allow for
monitoring of ribosome assembly landscapes in hitherto
unmatched resolution. Assembly intermediates can be
precisely detected and unambiguously allocated to either
the large or small ribosomal subunit. Rather than re-
placing quantitative mass spectrometry approaches, it
is supposed to be a valuable method to select the opti-
mal fractions for subsequent mass spectrometric or
structural analyses. Therefore, we believe that MCrg*
significantly enriches the tool kit for a more thorough
investigation of ribosome assembly and characterization
of new classes of antimicrobials. The methodology de-
scribed here might also be applied to eukaryotic systems
from yeast up to mammalian cells, using CRISPR Cas 9
based knock-in techniques [55-57] to screen for small
molecule inhibitors of eukaryotic ribosome assembly.
The high metabolic activity of tumor cells goes along
with high rates of protein production, which is expected
to make them more susceptible towards inhibition of the
translation apparatus than normal cells [58]. Therefore,
molecules found in such screenings could be the basis
for the development of new anti-cancer drugs.
Methods
Media, buffers, antibodies and antibiotics
LB medium (5 g yeast extract, 10 g trypton, 5 g NaCl/ l);
M9 medium (64 g Na2HPO4
. 7H2O, 15 g KH2PO4, 2.5 g
NaCl, 5 g NH4Cl, 2 mM MgSO4, 0.1 mM CaCl2, 0.4%
glucose/l); PBS (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4, pH 7.4); S15 and L1 specific
antisera, raised in sheep were obtained from Dr. Nierhaus.
Horseradish peroxidase (HRP)-conjugated rabbit anti-
sheep (CodeNo: 313-035-003; LotNo: 106383) and donkey
anti-rabbit (CodeNo: 711-035-152; LotNo: 103871) sec-
ondary antibodies were from Jackson ImmunoResearch.
HRP-substrate: for detection a mixture of 1 ml solution
A + 100 μl solution B + 1 μl solution C was freshly pre-
pared (solution A: 0.1 mM TRIS (pH8.6), 25 mg Luminol,
100 ml distilled H20; solution B: 11 mg p-hydroxycouma-
ric acid, in 10 ml DMSO; solution C: H2O2 (30%). Antibi-
otics were used in concentrations as indicated: Ampicillin
(Applichem-A0839,0100), chloramphenicol (Sigma-C0378),
erythromycin (Sigma-E6367), kanamycin (Roth-T832.4)
and neomycin (Sigma-N1876).
Plasmids and bacterial strains
rpsQ and rplC were amplified from genomic E. coli DNA
using specific primers with SacI and XbaI restriction sites,
respectively. Digested inserts were ligated with an opened
pTRC99a vector (lacIq, trc promoter, bla-gene forampicillin resistance) [59] using SacI/ XbaI restriction
sites generating pTRC-rplQ and pTRC-rplC, respect-
ively. Plasmids were brought into DH5α-Z1 by chemical
transformation for amplification and were isolated using
Qiagen mini-prep kit.
MC4100 (F− [araD139]B/r Δ(argF-lac)169 lambda
− e14-
flhD5301 Δ(fruK-yeiR)725 (fruA25) relA1 rpsL150(strR)
rbsR22 Δ(fimB-fimE)632(::IS1) deoC1); DY330 (W3110 Δ
lacU169 gal490 λcI857 Δ (cro-bioA))[36], DH5α-Z1 (F endA1
hsdR17(rk mk+) supE44 thi-1 recA1 gyrA relA1 Δ (lacZYA-
argF)U169 deoR Ф80 lacZΔM15 LacR TetR and Spr) [60]
λ-red recombineering
Coding sequences of mAzami green [27] (hereafter
mAzami) and mCherry (fused with kanamycin resistance
cassettes (kanR) derived from plasmid pKD4 [35]) with
flanking homologous regions (40–50 nucleotides) for
3’prime genomic insertion in frame with rplA and rpsO, re-
spectively, were amplified using Phusion DNA-Polymerase.
PCR products of the expected size were purified and
brought into competent DY330 cells via electroporation.
Successful genomic integration was verified by colony PCR
and DNA-sequencing. Genetic modifications were trans-
ferred to strains of interest using P1-phage transduction.
Resistance cassettes were eliminated by transforming strains
of interest with pCP20 [61] encoding FLP-recombinase
from Saccharomyces cerevisiae, which eliminates kanR
flanked by FRT-sites. Strains were cured from pCP20 by in-
cubation at 42°C for 15 hours. Gene deletions of rpsQ and
rplC were achieved as described previously [26].
Cell growth analysis
Growth on LB agar plates: Stationary E. coli cells were di-
luted in LB medium to an initial cell density of OD600 =
0.025. 1:5 serial dilutions were prepared and transferred to
LB agar plates with a plating stamp. Agar plates were incu-
bated at 20, 30, 37 and 42°C until visible single colonies
had formed.
Growth in liquid media: Stationary E. coli cells as indi-
cated (cultured in LB medium) were diluted in LB medium
to an initial cell density of OD600 = 0.05 (for incubation at
20°C) or 0.025 (for incubation at 37 and 42°C). Alterna-
tively, stationary pre-cultures of the indicated strains were
washed and diluted in M9 medium to an initial cell density
of OD600 = 0.05. Cell suspensions were cultured in baffled
flasks in a water bath incubator with a shaking frequency of
200 rpm until stationary phase was reached or a maximum
of 10 hours had passed. Cell density was determined using
a photometer (Amersham ultrospec 3110 pro). Growth
rates were calculated for periods of exponential growth.
SDS-PAGE and immunoblot analysis of purified ribosomes
Proteins from cell lysates (20 μg total protein) and puri-
fied ribosomes (15 pmol) from the indicated strains were
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Coomassie brilliant blue 250G.
For immunoblot analysis proteins from cell lysates (3 μg
total protein) and purified ribosomes (3 pmol) were re-
solved by a 13% SDS gel and blotted to nitrocellulose
membranes, which were decorated with S15 (raised in
rabbit) and L1 (raised in sheep) specific anti-sera (1:10000
and 1:15000 in TBS +3% milk powder). HRP-conjugated
donkey anti-rabbit and rabbit anti-sheep secondary anti-
body (1:20000 and 1:10000 in TBS + 3% milk powder)
were used in combination with HRP-substrate to allow
immunodetection. Chemiluminescence was monitored
using LAS 3000 imager (Fuji Film).
Purification of ribosomes by sucrose cushion centrifugation
E. coli cells were cultured in LB medium at 37°C to cell
densities as indicated, harvested by centrifugation and
processed as described previously [26].
Sucrose gradient centrifugation and ribosome analysis
Stationary pre-cultures of the individual strains were
washed and diluted in M9 medium to OD600 = 0.05 and
cultured at 37°C to cell densities as indicated. Chloram-
phenicol (250 μg/ml) was added 5 min before cells were
harvested by centrifugation, flash-frozen, and stored
at −80°C. Frozen cell pellets were resuspended in buffer
IV (10 mM TRIS, 10 mM MgCl2, 100 mM NH4Cl,
250 μM chloramphenicol, pH7.5) and cells were lyzed
using Fastprep-24. Cleared lysates (0.5 ml of a solution
with A260 = 15 or 20) were loaded on 10-40% sucrose
gradients (in buffer V: 10 mM TRIS, 10 mM MgCl2,
100 mM NH4Cl, 0.5 mM DTT, 1xTM Complete, pH7.5)
and centrifuged in a Sorvall TH-641 rotor for 2:40 h
at 41 krpm. A254 profiles of sucrose centrifugates were
obtained using a Teledyne Isco gradient reader. Fractions
of the sucrose gradient were collected in 96-well plates
(5 drops per well) for further fluorometric analysis.
For testing MCrg* with antibiotics, cells were washed
and diluted in M9 medium to OD600 = 0.1 and grown to
OD600 = 0.15 before chloramphenicol (7 μg/ml), erythro-
mycin (100 μg/ml), kanamycin (7 μg/ml) or neomycin
(7 μg/ml) were added. Cells were cultured at 25°C. After
3 hours of incubation cells were harvested and processed
as described above with two exceptions: No Chloram-
phenicol was added 5 min before harvesting and 10-25%
sucrose gradients were used for separation of ribosomal
particles.
Agarose gel electrophoresis
20 μl of sucrose gradient fractions were mixed with
6xDNA sample buffer (Thermo Scientific) and loaded
on a 1% agarose gel. The RNA content was separated at
150 V for 1 hour. The gel was stained in an ethidium
bromide solution for 15 min and RNA bands werevisualized at 302 nm on an UV-transilluminator (UVP)
by optical inspection.
Fluorometric analyses
Manual measurements using Fluorospectrometer (Jasco
FP-6500): 1 ml aliquots of cell suspension of various
strains were transferred to quartz cuvettes and mAzami-
(excitation 480 nm/ emission 510 nm ± 5 nm band
width) and mCherry specific fluorescence intensities (ex-
citation 580 nm/ emission 610 nm ± 5 nm band width)
were determined. Fluorescence ratios were calculated by
dividing mAzami by mCherry fluorescence intensities.
Ratios were normalized to the reporter strain (MCrg*)
and plotted in bar charts.
For the fully automated in vivo assay a Freedom EVO®
200 robotic platform (Tecan) was used, as described be-
fore [26]. Briefly, stationary cells of various strains were
washed and diluted in M9 medium to a cell density of
OD600 = 0.05. 80 μl aliquots of each strain were trans-
ferred to a 384-well plate in quadruplicates. Cells were
incubated for 10 hours at 37°C in a monitored incubator
(MIO2™) with 8.5 Hz shaking frequency. The samples
were analyzed in a microplate reader in one-hour inter-
vals for mAzami- and mCherry specific fluorescence,
using filter combinations 485/535 nm and 535/612 nm,
respectively. Fluorescence ratios were calculated by div-
iding mAzami by mCherry fluorescence intensities.
Background corrected ratios were normalized to the re-
porter strain (MCrg*) and plotted in bar charts. Cell
densities were determined simultaneously by detecting
the absorbance at 650 nm ± 5 nm (A650). Obtained
values were plotted in a spread chart. Calculations and
diagrams were made using Magellan 7 (Tecan) and
Graph Pad Prism v6 (Graph Pad) software packages.
Sucrose fraction were analyzed using an Infinite F500
(Tecan) fluorescence microplate reader. Sucrose gradient
fractions collected in 96-well plates (5 drops per well) were
analyzed for mAzami- and mCherry specific fluorescence
using filter combinations 485/535 nm and 535/612 nm, re-
spectively. Fluorescence intensities were normalized to a
fraction containing the first polysome (“disome”) peak, as
indicated. In Figure 4 and Figures based on it, the polysome
peaks are not shown. Nevertheless, in each case the first
polysome peak was used for normalization.
Additional files
Additional file 1: Overview constructed strains and 70S ribosome
structure. (A) Surface representation of a T. termophilus 70S ribosome
crystal structure. The 16S rRNA is colored in light gray proteins of the
small subunit in yellow. 23S and 5S rRNA are shown in dark gray,
proteins of the large subunit in cyan. S15 is highlighted in red, L1 in
green. Their surface exposed C-termini are shown in purple. The figure
was generated with pymol, based on PDB files 4KCZ and 4KCY (29).
(B) Given are the names of the constructed strains as used in this study
Nikolay et al. BMC Molecular Biology  (2015) 16:3 Page 11 of 12(lab nomenclature in brackets), relevant genotype and fluorescent fusion
proteins produced. pTRC-rpsQ, pTRC-rplC: complementation plasmids
with copies of the chromosomally deleted genes. Endogenous genes are
shown as gray arrows, genes encoding fluorescent proteins as colored
boxes. Genes to be deleted were replaced by kanamycin resistance
cassettes (KanR). mCherry gene and protein portions are shown in red,
mAzami accordingly in green.
Additional file 2: in vivo 30S and 50S ribosome assembly maps
adapted from [10]. (A) 30S assembly map reflecting order and
interdependency of r-protein interaction with the nascent small
ribosomal subunit. Early interacting r-proteins are shaded in dark gray,
late interacting ones in light gray. Boxed proteins are contained in the
21S precursor of the 30S subunit. S15 is circled in red. (B) 50S assembly
map reflecting order and interdependency of r-protein interaction with
the nascent large ribosomal subunit. Early interacting r-proteins are
shaded in dark gray, late interacting ones in light gray. Proteins contained
in the 32S or in the 43S precursor of the large ribosomal subunit are
boxed or circled in black, respectively. L1 is circled in green.
Additional file 3: Alignment of mAzami specific fluorescence
intensities from samples analyzed in Figure 4. mAzami fluorescence
profiles from untreated cells in combination with mAzami profiles
derived from (A) chloramphenicol (Cam), (B) erythromycin (Ery), (C)
kanamycin (Kan) and (D) neomycin (Neo) treated cells. The diagrams
show normalized mAzami fluorescence intensities from sucrose fractions
derived from untreated cells (gray bars) in direct comparison with the
ones from antibiotic treated cells (green bars). 70S peaks were used for
normalization.
Additional file 4: Alignment of mCherry specific fluorescence
intensities from samples analyzed in Figure 4. mCherry fluorescence
profiles from untreated cells in combination with mCherry profiles
derived from (A) chloramphenicol (Cam), (B) erythromycin (Ery), (C)
kanamycin (Kan) and (D) neomycin (Neo) treated cells. The diagrams
show normalized mCherry fluorescence intensities from sucrose fractions
derived from untreated cells (gray bars) in direct comparison with the
ones from antibiotic treated cells (red bars). 70S peaks were used for
normalization.
Additional file 5: A254 detection and fluorescence analysis of
sucrose density gradient fractions. Sucrose density gradient (10-25%)
centrifugation profiles derived from (A) control cells with no antibiotic
(none), (B) chloramphenicol (Cam), (C) erythromycin (Ery), (D) kanamycin
(Kan) and (E) neomycin (Neo) treated cells. Sucrose fractions were
collected and analyzed for mAzami and mCherry specific fluorescence
(green and red bars). A254 profiles and fluorescence bar charts were
superimposed and sucrose fractions were analyzed for presence of
16S and 23S rRNA by agarose gelelectrophoresis and subsequent
optical inspection. Open circles: No rRNA, gray circles: fractions with
low-intermediate amounts of rRNA, black circles: fractions with high
amounts of rRNA.Abbreviations
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